NEW YORK (GenomeWeb News) – Third Wave Technologies said yesterday that it has field a shelf registration with the US Securities and Exchange Commission allowing it to sell up to $100 million in securities.
 
The molecular diagnostics company said it may sell an undetermined number of debt securities or common stock, which includes the rights to purchase preferred stock, and that all of these may be issued by exercising warrants.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.